ANL 22.33 Decreased By ▼ -1.86 (-7.69%)
ASC 14.60 Decreased By ▼ -0.60 (-3.95%)
ASL 23.65 Increased By ▲ 1.65 (7.5%)
BOP 8.28 Decreased By ▼ -0.14 (-1.66%)
BYCO 8.15 Decreased By ▼ -0.31 (-3.66%)
FCCL 17.97 Increased By ▲ 0.57 (3.28%)
FFBL 23.48 Decreased By ▼ -0.74 (-3.06%)
FFL 16.10 Decreased By ▼ -0.80 (-4.73%)
FNEL 7.97 Decreased By ▼ -0.18 (-2.21%)
GGGL 19.40 Decreased By ▼ -1.29 (-6.23%)
GGL 41.74 Increased By ▲ 0.21 (0.51%)
HUMNL 6.34 Decreased By ▼ -0.21 (-3.21%)
JSCL 19.37 Decreased By ▼ -0.76 (-3.78%)
KAPCO 37.18 Decreased By ▼ -0.32 (-0.85%)
KEL 3.48 Decreased By ▼ -0.03 (-0.85%)
MDTL 2.70 Decreased By ▼ -0.25 (-8.47%)
MLCF 34.99 Decreased By ▼ -0.06 (-0.17%)
NETSOL 139.30 Decreased By ▼ -5.55 (-3.83%)
PACE 5.12 Decreased By ▼ -0.85 (-14.24%)
PAEL 28.35 Decreased By ▼ -1.74 (-5.78%)
PIBTL 8.90 Decreased By ▼ -0.27 (-2.94%)
POWER 7.30 Decreased By ▼ -0.30 (-3.95%)
PRL 18.30 Decreased By ▼ -0.95 (-4.94%)
PTC 10.00 Decreased By ▼ -0.12 (-1.19%)
SILK 1.51 Decreased By ▼ -0.11 (-6.79%)
SNGP 45.30 Increased By ▲ 1.80 (4.14%)
TELE 20.41 Decreased By ▼ -1.59 (-7.23%)
TRG 169.50 Decreased By ▼ -1.00 (-0.59%)
UNITY 33.05 Decreased By ▼ -0.89 (-2.62%)
WTL 2.96 Decreased By ▼ -0.13 (-4.21%)
BR100 4,822 Decreased By ▼ -36.54 (-0.75%)
BR30 23,477 Decreased By ▼ -388.55 (-1.63%)
KSE100 45,597 Decreased By ▼ -411.61 (-0.89%)
KSE30 18,029 Decreased By ▼ -149.92 (-0.82%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,432
5824hr
Pakistan Cases
1,232,595
2,35724hr
4.9% positivity
Sindh
453,051
Punjab
425,703
Balochistan
32,812
Islamabad
104,619
KPK
172,210

ISLAMABAD: The Cabinet has approved Maximum Retail Price (MRP) of new drug Favipiravir 200 mgs tablets on the recommendation of Drug Regulatory Authority of Pakistan (DRAP).

On July 13, the National Health Services Regulations & Coordination Division briefed the Cabinet that Section 12 of the Drugs Act, 1976 and Section 7 of the Drug Regulatory Authority of Pakistan (DRAP) Act, 2012 empowered the Federal Government to fix Maximum Retail Prices of drugs to be sold in the market. Further, drugs price fixation mechanism had been detailed in Drug Pricing Policy 2018 and amended with the approval of Federal Government through a notification of July 15, 2020.

The sources said, Drug Pricing Committee (DPC) of DRAP constituted vide SRO No.707(I)/2013 was empowered to determine the MRPs of drugs.

DRAP had submitted recommendations after the 42nd meeting of the Drug Pricing Committee (DPC) held on July 6, 2020 wherein MRP of one new drug Favipiravir 200 mg tablets was determined in different pack sizes as follows: (i) Rs3,000 10's; (ii) Rs5,880 20's; (iii) Rs8,640 30's; (iv) Rs14,400 50's and; (v) Rs28,800 100's.

The MRP of drug has become effective after the notification duly issued with the approval of Federal Government under the authority vested in terms of Section-12 of the Drugs Act, L976 and Section 7 of DRAP Act, 2012.

Copyright Business Recorder, 2021

Comments

Comments are closed.